Over the past decade, more and more Japanese pharmaceutical companies have entered the U.S. market in an effort to establish a global presence. This panel will address the ways in which Japanese-based companies can successfully enter the U.S. pharmaceutical market and leverage in-licensing, partnering and product acquisitions through an established specialty focus.



Objectives:

Provide insight and advice from leaders in the pharmaceutical industry who have established a specialty focus will provide the audience with valuable knowledge that may give them the edge in establishing their own specialty business.

Learn about the challenges and opportunities of establishing a specialty area in the highly saturated U.S. marketplace.

Better understand how to build a specialty focus through product acquisitions, copromotion deals and R&D licensing.